Advertisement
AAME vs PKIN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAME is a StrongBuy and PKIN is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AAME’s FA Score shows that 0 FA rating(s) are green whilePKIN’s FA Score has 1 green FA rating(s).
- AAME’s FA Score: 0 green, 5 red.
- PKIN’s FA Score: 1 green, 4 red.
Price Growth
AAME (@Life/Health Insurance) experienced а +6.40% price change this week, while PKIN (@Life/Health Insurance) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -0.92%. For the same industry, the average monthly price growth was -1.01%, and the average quarterly price growth was +4.57%.
Industries' Descriptions
@Life/Health Insurance (-0.92% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| AAME | PKIN | AAME / PKIN | |
| Capitalization | 57.1M | 160M | 36% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 20.673 | 0.000 | - |
| P/E Ratio | 20.00 | N/A | - |
| Revenue | 185M | N/A | - |
| Total Cash | 24.3M | N/A | - |
| Total Debt | 36.8M | N/A | - |
AAME | PKIN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 43 Fair valued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 96 | 100 | |
SMR RATING 1..100 | 91 | 100 | |
PRICE GROWTH RATING 1..100 | 43 | 56 | |
P/E GROWTH RATING 1..100 | 47 | 9 | |
SEASONALITY SCORE 1..100 | n/a | 38 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AAME's Valuation (43) in the Multi Line Insurance industry is somewhat better than the same rating for PKIN (97) in the null industry. This means that AAME’s stock grew somewhat faster than PKIN’s over the last 12 months.
AAME's Profit vs Risk Rating (96) in the Multi Line Insurance industry is in the same range as PKIN (100) in the null industry. This means that AAME’s stock grew similarly to PKIN’s over the last 12 months.
AAME's SMR Rating (91) in the Multi Line Insurance industry is in the same range as PKIN (100) in the null industry. This means that AAME’s stock grew similarly to PKIN’s over the last 12 months.
AAME's Price Growth Rating (43) in the Multi Line Insurance industry is in the same range as PKIN (56) in the null industry. This means that AAME’s stock grew similarly to PKIN’s over the last 12 months.
PKIN's P/E Growth Rating (9) in the null industry is somewhat better than the same rating for AAME (47) in the Multi Line Insurance industry. This means that PKIN’s stock grew somewhat faster than AAME’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VTMFX | 45.52 | -0.28 | -0.61% |
| Vanguard Tax-Managed Balanced Adm | |||
| OFVIX | 20.05 | -0.22 | -1.09% |
| O'Shaughnessy Market Leaders Value I | |||
| AMANX | 68.11 | -0.77 | -1.12% |
| Amana Income Investor | |||
| PNGAX | 15.86 | -0.22 | -1.37% |
| Putnam International Value A | |||
| MDODX | 10.91 | -0.17 | -1.53% |
| Morgan Stanley Developing Opportunity R6 | |||
AAME and
Correlation & Price change
A.I.dvisor tells us that AAME and PKIN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AAME and PKIN's prices will move in lockstep.
| Ticker / NAME | Correlation To AAME | 1D Price Change % | ||
|---|---|---|---|---|
| AAME | 100% | -0.54% | ||
| PKIN - AAME | 23% Poorly correlated | N/A | ||
| MET - AAME | 19% Poorly correlated | -2.08% | ||
| PRU - AAME | 15% Poorly correlated | -1.84% | ||
| AFL - AAME | 14% Poorly correlated | -0.44% | ||
| MFC - AAME | 14% Poorly correlated | -2.99% | ||
More | ||||
PKIN and
Correlation & Price change
A.I.dvisor tells us that PKIN and AAME have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PKIN and AAME's prices will move in lockstep.
| Ticker / NAME | Correlation To PKIN | 1D Price Change % | ||
|---|---|---|---|---|
| PKIN | 100% | N/A | ||
| AAME - PKIN | 23% Poorly correlated | -0.54% | ||
| SLLDY - PKIN | 7% Poorly correlated | -2.89% | ||
| PNGAY - PKIN | 7% Poorly correlated | -2.17% | ||
| SGCFF - PKIN | 1% Poorly correlated | N/A | ||
| PUKPF - PKIN | 1% Poorly correlated | -7.49% | ||
More | ||||